Acuitas Investments, LLC Adagio Therapeutics, Inc. Transaction History
Acuitas Investments, LLC
- $189 Million
- Q1 2024
A detailed history of Acuitas Investments, LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 77,195 shares of ADGI stock, worth $255,515. This represents 0.13% of its overall portfolio holdings.
Number of Shares
77,195
Previous 208,640
63.0%
Holding current value
$255,515
Previous $690,000
63.04%
% of portfolio
0.13%
Previous 0.37%
Shares
3 transactions
Others Institutions Holding ADGI
# of Institutions
93Shares Held
64MCall Options Held
828KPut Options Held
23.4K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.77% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.2% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million28.73% of portfolio
-
Alphabet Inc. Mountain View, CA4.53MShares$15 Million0.66% of portfolio
-
Slate Path Capital LP New York, NY3.74MShares$12.4 Million0.25% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...